Search
Ovarian-Cancer-organoid
Cancer Organoid

Ovarian Cancer Organoid

1784€+
Cancer Organoid

Ovarian Cancer Organoid

  • Ovarian cancer organoids are three-dimensional (3D) models that closely replicate the structure and cellular composition of actual cancer tissue.
  • By preserving key characteristics of ovarian cancer, including genetic mutations and protein expression patterns, these organoids serve as reliable models for cancer research.
  • Their ability to maintain tumor heterogeneity and accurately mimic the tumor microenvironment (TME) makes them invaluable for studying disease progression and treatment responses.
  • As physiologically relevant models, ovarian cancer organoids play a crucial role in advancing precision medicine and facilitating the development of more effective cancer therapies.

Price
Organism
Human
Product Type
Tissue derived organoid
Tissue
Ovary
Disease
Ovarian Cancer

Applications

Toxicity

Small molecules

mRNA

Antibody

Cancer vaccine

Immune Cells

Immuno Oncology with TME

Cytotoxic T cell

TIL (Tumor infiltrating lymphocytes)

Regulatory T cell

Macrophage

CAF (Cancer associate fibroblast)

Professor Lee Chang-seok Eulji University
Customer insight

Advancing K-Beauty with Skin Organoids: A Next-Generation Platform for Non-Animal Testing and High-Precision Cosmetic Innovation

With the global rise of K-beauty, the cosmetics industry continues to grow steadily. Since the ban on animal testing for cosmetics in Korea in 2017, various alternative testing methods have...

Tomocube (Spatial)
Customer insight

HT-X1: A Label-Free Imaging Breakthrough for Organoid-Based Disease Modeling and Drug Screening

Traditional microscopy methods often require fluorescent labeling to analyze cellular structures, which can be time-consuming and invasive. In contrast, our HT-X1 system allows for high-resolution visualization of cellular morphology without...

Seoul National University College of Medicine
Customer insight

Pioneering Spatial Protein Analysis in Korea: Advancing Clinical Pathology with Lambda Biologics’ Support

Traditional protein analysis has primarily focused on quantifying expression levels within tissue samples. However, recent advances in spatial analysis techniques have shifted attention toward evaluating not only expression levels, but...

K Research Institute
Customer insight

ODISEI-Gut Platform Reveals Immune-Boosting Potential of Kimchi-Derived Bacterial Strain

Among the many fermented foods we consume, kimchi is particularly known for containing a diverse range of lactic acid bacteria, which are believed to influence the activation of immune cells...

Bundang Jesaeng General Hospital
Customer insight

Multiplex Marker Analysis Enhances Research Efficiency with 31-Marker Detection on a Single Slide

We conducted a study focused on identifying disease-related markers using patient-derived tissue samples. However, traditional methods limited our ability to analyze multiple candidate markers simultaneously, and the limited availability of...

Description

Cellular and structural similarity

Our ovarian cancer organoids exhibit high pathological similarity to patient-derived tumor tissues, expressing key ovarian cancer markers such as CA125, HE4, PAX8 and WT1.

Immunohistochemistry (IHC) analyses confirm that these markers are expressed in the organoids in patterns consistent with primary tumors, reflecting their differentiation status and histological characteristics.

These pathological marker analyses demonstrate that ovarian cancer organoids faithfully recapitulate the morphological and molecular features of patient tumors, making them a reliable platform for cancer pathology research, drug development, and personalized therapy evaluation.

Drug sensitivity testing for Precision Oncology

A tailored solution for evaluating the efficacy and resistance of new drugs is available using an established ovarian cancer (OVC) organoid library.

By leveraging comprehensive drug sensitivity data, the most suitable organoid lines are selected based on the characteristics of the investigational drug, enabling precise and reliable drug testing.

Drug sensitivity tests have been conducted using Carboplatin, Cisplatin and Paclitaxel which are widely used in clinical cancer treatment, and drug response data from a subset of OVC organoid models has been collected.

This dataset continues to expand as additional testing is performed.

This organoid-based drug sensitivity testing platform enhances the efficiency and reliability of the drug development process and contributes to the advancement of personalized cancer treatment strategies.

Connect with Us